fbpx
QQQ
+ 0.00
341.01
+ 0%
DIA
-0.02
340.78
-0.01%
SPY
+ 0.15
421.96
+ 0.04%
TLT
+ 0.00
140.93
+ 0%
GLD
-0.02
171.13
-0.01%

Deutsche Bank Initiates CONMED With Buy

by
May 4, 2015 9:20 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Analysts at Deutsche Bank initiated coverage on CONMED Corporation (NASDAQ: CNMD) with a Buy rating.

The target price for CONMED is set to $63.

CONMED shares have gained 7.29 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period.

CONMED shares closed at $50.16 on Friday.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

CONMED Shares Initiated With Buy At Deutsche Bank

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021

  read more

Barclays Initiates Coverage On Conmed with Overweight Rating, Announces Price Target of $175

Barclays analyst Travis Steed initiates coverage on Conmed (NYSE:CNMD) with a Overweight rating and announces Price Target of $175. read more

Benzinga's Top Upgrades, Downgrades For November 26, 2019